European regulatory perspectives for innovative therapies

S. Ormarsdottir, J.-Y. Reginster, E. Abadie

January 21 2008

S. Ormarsdottir, J.-Y. Reginster, E. Abadie

S. Ormarsdottir
CHMP member, Senior Expert, Icelandic Medicines Control Agency, Seltjarnarnes, Iceland

J.-Y. Reginster
President, European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO);

J.-Y. Reginster
President, Group for the Respect of Ethics and Excellence in Science (GREES); CHMP Expert, Liege, Belgium

E. Abadie
CHMP chair, EMEA and Scientific Advisor, General Directorate, AFSSAPS, Saint-Denis, France

J.-Y. Reginster
Bone and Cartilage Metabolism Research Unit, CHU Centre-Ville, Policliniques L. Brull, Quai Godefroid Kurth 45 (9ème étage), 4020 Liege, Belgium


Aging clinical and experimental research offers a multidisciplinary forum on the progressing field of gerontology and geriatrics. The areas covered by the journal include: biogerontology, neurosciences, epidemiology, clinical gerontology and geriatric assessment, social, economical and behavioral gerontology. “Aging clinical and experimental research” appears bimonthly and publishes review articles, original papers and case reports.

Discover the official journal of ESCEO on and read the journal contents on
You can get the table of contents of every new issue published in Aging Clinical and Experimental Research. Sign up for the ToC Alert for this journal with your e-mail address. It’s easy and it’s free.